ERBB2 and breast carcinoma: In breast cancer, promoter CpG island hypermethylation has been described for genes involved in all aspects of cellular function and was found to be associated with various histopathologic characteristics, including tumor grade [5], [6], hormone receptor [7], [8], HER2/neu status [9] and molecular subtype [10]–[13].